PrecisemAb Biotech was pleased to once again participate as part of the Taiwan delegation at BIO 2026 in San Diego, joining biotech and pharmaceutical companies, investors, industry experts, and potential partners from around the world.
This year’s participation provided an important opportunity for PrecisemAb Biotech to expand its international business development efforts and strengthen its global industry network. Through partnering meetings, technology discussions, and cross-border engagement during the event, our team was able to introduce PrecisemAb’s Antibody Lock platform and share our capabilities in developing safer and more disease-selective antibody therapeutics.
We are honored to have joined the Taiwan Pavilion once again and to stand alongside Taiwan’s biotech innovators on the global stage. Moving forward, PrecisemAb Biotech will continue to advance its international collaboration strategy, explore global business opportunities, and bring its innovative antibody engineering technologies closer to international partnerships and future clinical translation.
NEWS: Global BIO